Literature DB >> 11096526

Giant Cell Arteritis.

.   

Abstract

Giant cell arteritis is a medium-vessel vasculitis that affects both men and women. Because the disease commonly presents with nonspecific complaints stemming from cranial arterial insufficiency, the challenge for the physician is recognizing the diagnosis. Recognition of the entity and expeditious initiation of therapy are required to prevent permanent complications, including blindness. There is no pathognomonic finding on physical examination, blood testing, or commonly used radiologic investigations to confirm the diagnosis or establish disease activity. Oral corticosteroids are the mainstay of therapy. Other immune system modulators have no demonstrated efficacy and require further investigation. Percutaneous or surgical revascularization is a viable therapeutic option when the disease is not active.

Entities:  

Year:  2000        PMID: 11096526     DOI: 10.1007/s11936-000-0015-0

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  27 in total

1.  Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study.

Authors:  G Nesher; A Rubinow; M Sonnenblick
Journal:  Clin Exp Rheumatol       Date:  1997 May-Jun       Impact factor: 4.473

2.  The classification and diagnosis of vasculitis in large and medium-sized blood vessels.

Authors:  J T Lie
Journal:  Pathol Annu       Date:  1987

3.  The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Authors:  V Petursdottir; H Johansson; E Nordborg; C Nordborg
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

Review 4.  Treatment of corticosteroid-resistant giant cell arteritis.

Authors:  W S Wilke; G S Hoffman
Journal:  Rheum Dis Clin North Am       Date:  1995-02       Impact factor: 2.670

5.  Takayasu's arteritis: evaluation with three-dimensional time-of-flight MR angiography.

Authors:  S Kumar; S Radhakrishnan; R V Phadke; R K Gupta; R Gujral
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 6.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

7.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

8.  Prevention of blindness in giant cell arteritis by corticosteroid treatment.

Authors:  A B Myles; T Perera; M G Ridley
Journal:  Br J Rheumatol       Date:  1992-02

9.  Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients.

Authors:  W L Chmelewski; K M McKnight; C A Agudelo; C M Wise
Journal:  Arch Intern Med       Date:  1992-08

10.  Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper extremity ischemic symptoms not responsive to corticosteroids.

Authors:  P F Dellaripa; A C Eisenhauer
Journal:  J Rheumatol       Date:  1998-07       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.